State Street’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

State Street’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-133,026	Closed	-$14.1M	–	3736
2014 Q2	$14.1M	Buy	133,026 +1,476	+1%	+$145K	﹤0.01%	2036
2014 Q1	$11.4M	Sell	131,550 -12,722	-9%	-$982K	﹤0.01%	2134
2013 Q4	$6.06M	Sell	144,272 -135	-0.1%	-$5.55K	﹤0.01%	2475
2013 Q3	$6.36M	Sell	144,407 -4,225	-3%	-$175K	﹤0.01%	2384
2013 Q2	$5.06M	Buy	+148,632	New	+$5.22M	﹤0.01%	2461

State Street's FURX Position: Q3 2014 in Review

State Street sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 133,026 shares — an estimated $14.1M sold.

State Street first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $14.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

State Street reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
State Street sold 133,026 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $14.1M.
State Street first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
State Street's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $14.1M in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on State Street's 13F filing for Q3 2014, filed 10 Nov 2014.